Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.16% is 36% below its 5-year average of 0.24%, near the low end of its 5-year range (0.16%–0.34%).
As of the fiscal period ended Tuesday, June 30, 2026. 14.79% below its 12-month average of 0.18%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.16%.
DEBT TO ASSETS RATIO
0.16%
DEBT TO ASSETS RATIO AVG TTM
0.18%
DEBT TO ASSETS RATIO AVG 3Y
0.21%
DEBT TO ASSETS RATIO AVG 5Y
0.24%
DEBT TO ASSETS RATIO AVG 10Y
0.20%
DEBT TO ASSETS RATIO AVG 15Y
0.18%
DEBT TO ASSETS RATIO AVG 20Y
3.68%
CURRENT VS TTM AVG
-14.79%
CURRENT VS 3Y AVG
-24.97%
CURRENT VS 5Y AVG
-35.70%
CURRENT VS 10Y AVG
-21.75%
CURRENT VS 15Y AVG
-12.20%
CURRENT VS 20Y AVG
-95.74%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+73.93%
vs the sector median at left
Utah Medical Products, Inc.
Market Cap
$235.08M
Debt to Assets Ratio
0.16%
TTM Avg
0.18%
3Y Avg
0.21%
5Y Avg
0.24%
Market Cap
$235.66M
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$235.97M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$231.77M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Utah Medical Products, Inc. (UTMD) | $235.08M | 0.16% | 0.18% | 0.21% | 0.24% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | 0.15% | N/A | N/A | N/A |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | 0.00% | N/A | N/A | N/A |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | 0.01% | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $232.72M | 0.00% | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $237.57M | 0.04% | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $231.77M | 0.00% | N/A | N/A | N/A |
| MacroGenics, Inc. (MGNX)vs › | $231.37M | 0.10% | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $239.01M | 0.33% | N/A | N/A | N/A |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | 0.12% | N/A | N/A | N/A |
Debt/Assets
0.2%
Debt/Equity
0.00
Current Ratio
48.62
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.16% |
| 2026-03-31 | 0.17% |
| 2025-12-31 | 0.18% |
| 2025-09-30 | 0.20% |
| 2025-06-30 | 0.21% |
| 2025-03-31 | 0.22% |
| 2024-12-31 | 0.23% |
| 2024-09-30 | 0.23% |
| 2024-06-30 | 0.21% |
| 2024-03-31 | 0.21% |
| 2023-12-31 | 0.22% |
| 2023-09-30 | 0.23% |
| 2023-06-30 | 0.24% |
| 2023-03-31 | 0.26% |
| 2022-12-31 | 0.28% |
| 2022-09-30 | 0.30% |
| 2022-06-30 | 0.32% |
| 2022-03-31 | 0.32% |
| 2021-12-31 | 0.34% |
| 2021-09-30 | 0.29% |
| 2021-06-30 | 0.30% |
| 2021-03-31 | 0.29% |
| 2020-12-31 | 0.30% |
| 2020-09-30 | 0.32% |
| 2020-06-30 | 0.34% |
| 2020-03-31 | 0.35% |
| 2019-12-31 | 0.34% |
| 2019-09-30 | 0.37% |
| 2019-06-30 | 0.38% |
| 2019-03-31 | 0.39% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 6.00% |
| 2014-09-30 | 7.28% |
| 2014-06-30 | 8.59% |
| 2014-03-31 | 9.81% |
| 2013-12-31 | 11.30% |
| 2013-09-30 | 12.37% |
| 2013-06-30 | 13.79% |
| 2013-03-31 | 15.05% |
| 2012-12-31 | 16.90% |
| 2012-09-30 | 18.86% |
| 2012-06-30 | 21.54% |
| 2012-03-31 | 24.42% |
| 2011-12-31 | 28.37% |
| 2011-09-30 | 30.36% |
| 2011-06-30 | 32.39% |
| 2011-03-31 | 34.08% |
| 2010-12-31 | 2.73% |
| 2010-09-30 | 2.87% |
| 2010-06-30 | 2.91% |
| 2010-03-31 | 3.49% |
| 2009-12-31 | 3.99% |
| 2009-09-30 | 4.09% |
| 2009-06-30 | 4.37% |
| 2009-03-31 | 4.29% |
| 2008-12-31 | 5.39% |
| 2008-09-30 | 5.65% |
| 2008-06-30 | 7.33% |
| 2008-03-31 | 8.81% |
| 2007-12-31 | 8.94% |
| 2007-09-30 | 9.71% |
| 2007-06-30 | 9.99% |
| 2007-03-31 | 10.23% |
| 2006-12-31 | 10.92% |
| 2006-09-30 | 11.48% |
| 2006-06-30 | 12.62% |
| 2006-03-31 | 12.43% |
| 2005-12-31 | 12.81% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 7.77% |
| 2003-03-31 | 12.45% |
| 2002-12-31 | 21.19% |
| 2002-09-30 | 0.00% |
